We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0HIY market cap is 131.1B. The company's latest EPS is USD -2.7092 and P/E is -4.12.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 20.34M | 63.57M | 8.57M |
| Operating Income | -295.68M | -309.05M | -340.46M | -280.51M | -276.01M |
| Net Income | -290.98M | -306.62M | -340.14M | -230M | -276.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 342.94M | 588.12M | 468.13M | 376.42M | 165.5M |
| Total Liabilities | 52.16M | 125.78M | 188.51M | 249.78M | 264.74M |
| Total Equity | 290.78M | 462.34M | 279.61M | 126.64M | -99.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -235.63M | -180.76M | -220.52M | -270.43M | -192.98M |
| Investing | 60.46M | -120.73M | 22.26M | 202.96M | 123.87M |
| Financing | 188.79M | 427.57M | 103.94M | 53.08M | 2.01M |
| Market Cap | 131.1B |
| Price to Earnings Ratio | -4.12 |
| Price to Sales Ratio | 132.82 |
| Price to Cash Ratio | 44.06 |
| Price to Book Ratio | -11.47 |
| Dividend Yield | - |
| Shares Outstanding | 101.92M |
| Average Volume (1 week) | 2.36k |
| Average Volume (1 Month) | 1.86k |
| 52 Week Change | 0.00% |
| 52 Week High | 1,286.25 |
| 52 Week Low | 1,286.25 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Atara Biotherapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atarabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
